ANSLEY BUCKHALTER: Open Payments
NPI 1639403710 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$858 in 24 payments from 6 companies in 2025. Trend: 2023 $615 · 2024 $718 · 2025 $858
Food & beverage: $858
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $342 |
| Madrigal Pharmaceuticals | 2 | $257 |
| Phathom Pharmaceuticals, Inc. | 8 | $186 |
| Janssen Biotech, Inc. | 1 | $30 |
| GENZYME CORPORATION | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
Products named: REZDIFFRA, RINVOQ, VOQUEZNA, SKYRIZI, TREMFYA, DUPIXENT, XIFAXAN.
Industry payments across KY — which companies pay providers there.
